Team
health

Carboplatin Calculator

Carboplatin dosing demands precision because the drug relies almost entirely on renal clearance for elimination. Oncologists use the Calvert formula to individualise doses based on each patient's glomerular filtration rate and target area under the curve (AUC). This calculator derives kidney function from basic clinical parameters—age, weight, sex, and serum creatinine—then computes the appropriate carboplatin milligram dose and safety ceiling for treating ovarian, lung, or brain cancers.

Last updated:

Creators Łucja Zaborowska, MD, PhD
3,399 people find this calculator helpful

The Calvert Formula for Carboplatin Dosing

The Calvert formula links drug exposure to renal clearance, ensuring efficacy without excessive toxicity. Two steps are required: first, estimate glomerular filtration rate using the Cockcroft–Gault equation; second, apply the Calvert equation to determine total dose.

GFR (mL/min) = Sex factor × [(140 − Age) ÷ Serum creatinine] × (Weight ÷ 72)

Carboplatin dose (mg) = Target AUC × (GFR + 25)

Maximum dose (mg) = Target AUC × 150

  • GFR — Glomerular filtration rate in mL/min; males use factor 1, females use 0.85
  • Age — Patient age in years
  • Weight — Patient body weight in kilograms
  • Serum creatinine — Serum creatinine level in mg/dL, a marker of kidney function
  • Target AUC — Area under the curve (mg·min/mL); typically 5–7 depending on cancer type and regimen
  • Maximum dose — Dose ceiling applied to patients with near-normal renal function to prevent overdosing

Understanding Glomerular Filtration Rate and Renal Adjustments

The glomerular filtration rate quantifies how efficiently the kidneys filter waste from blood. Since carboplatin is eliminated almost exclusively via the urine, patients with reduced kidney function require lower doses to avoid accumulation and toxicity.

The Cockcroft–Gault equation incorporates four clinical variables:

  • Age — older kidneys typically filter less efficiently
  • Weight — larger individuals usually have higher baseline GFR
  • Sex — women receive a 15% downward adjustment (0.85 factor) because they typically have lower creatinine generation per kilogram
  • Serum creatinine — an inverse relationship; higher creatinine indicates lower GFR

Once GFR is established, adding 25 to this value accounts for tubular secretion of carboplatin in addition to glomerular filtration. The resulting sum is then multiplied by the target AUC to yield the individualized dose.

Target AUC and Maximum Carboplatin Dose Considerations

The area under the curve (AUC) represents cumulative drug exposure over time and directly governs dose magnitude. Clinical trials have established that carboplatin AUC values between 5 and 7 mg·min/mL are therapeutically optimal for most regimens; higher AUC values correlate with increased myelosuppression and other toxicities.

To protect patients with normal or near-normal kidney function from excessive dosing, the formula caps GFR at 125 mL/min before calculating the maximum permissible dose:

  • For a patient with excellent renal function (GFR 140 mL/min), the formula uses 125 instead, yielding a maximum dose of AUC × 150 mg
  • This ceiling prevents mathematical inflation of dose in younger, healthier individuals
  • Patients with GFR below 125 mL/min use their actual measured value, not the cap

Always verify the final calculated dose against institutional pharmacy guidelines and the prescribing physician's clinical judgment before administration.

Critical Pitfalls and Safety Considerations

Carboplatin dosing errors carry serious consequences; heed these common sources of miscalculation or misapplication.

  1. Serum Creatinine Unit Confusion — Ensure serum creatinine is recorded in mg/dL before entering it into the Cockcroft–Gault equation. If your laboratory reports creatinine in µmol/L, divide by 88.4 to convert. A ten-fold unit error will yield a GFR that is wildly inaccurate and jeopardise patient safety.
  2. Acute Kidney Injury or Recent Changes — The Cockcroft–Gault equation assumes stable renal function. If a patient has experienced recent acute kidney injury, contrast exposure, dehydration, or medication changes affecting creatinine, the calculated GFR may not reflect true clearance. Repeat serum creatinine measurement and consider cystatin-C if creatinine is unreliable.
  3. Body Weight Selection in Obese Patients — Using total body weight in obese patients can overestimate GFR and lead to overdosing. Some oncologists prefer adjusted or lean body weight formulas; discuss with the treating physician which weight metric is appropriate for your patient population.
  4. Timing of Renal Function Assessment — GFR should be measured shortly before carboplatin administration. A patient's kidney function can deteriorate over weeks or months, especially after prior chemotherapy. Dosing based on renal function from several months ago may be dangerously inaccurate.

Practical Example of Carboplatin Dose Calculation

Consider a 55-year-old woman weighing 68 kg with serum creatinine of 0.9 mg/dL being treated for recurrent ovarian cancer with a target AUC of 6.

Step 1: Calculate GFR using Cockcroft–Gault

  • GFR = 0.85 × [(140 − 55) ÷ 0.9] × (68 ÷ 72)
  • GFR = 0.85 × [85 ÷ 0.9] × 0.944
  • GFR = 0.85 × 94.4 × 0.944
  • GFR ≈ 75.5 mL/min

Step 2: Apply Calvert formula

  • Carboplatin dose = 6 × (75.5 + 25) = 6 × 100.5 = 603 mg
  • Maximum allowable dose = 6 × 150 = 900 mg

In this case, 603 mg is well below the maximum, making it the appropriate dose. The oncology team would typically round to 600 mg for practical administration.

Frequently Asked Questions

Why must carboplatin dosing account for kidney function?

Carboplatin undergoes minimal hepatic metabolism and is eliminated almost entirely through renal filtration and secretion. In patients with impaired kidney function, the drug accumulates in the bloodstream, prolonging exposure and increasing the risk of severe bone marrow suppression, infection, and other toxicities. The Calvert formula ensures that dose intensity is proportional to each patient's ability to clear the drug, thereby maintaining efficacy while minimising harm.

What happens if carboplatin dose is calculated incorrectly?

Underdosing may result in subtherapeutic drug exposure, reducing cancer response rates and allowing tumour progression. Overdosing causes excessive myelosuppression—profound drops in white blood cells, platelets, and red blood cells—leading to infections, bleeding, transfusion dependence, and potentially life-threatening complications. Severe renal or hepatic damage can also occur. This is why precise dosing calculations and verification by pharmacists and physicians are non-negotiable.

Can the Calvert formula be used for all chemotherapy drugs?

No. The Calvert formula is specifically designed for carboplatin because of its unique pharmacokinetics and primary renal elimination. Other platinum agents like cisplatin or oxaliplatin follow different dosing schemas. Additionally, many non-platinum drugs rely on hepatic metabolism or have different target exposure metrics (e.g., body surface area dosing), making the Calvert formula inappropriate for them.

What is the difference between measured GFR and estimated GFR?

Measured GFR typically comes from a 24-hour urine collection measuring inulin or radioisotope clearance and is considered the gold standard but is cumbersome and rarely done in routine practice. Estimated GFR uses equations like Cockcroft–Gault, MDRD, or CKD-EPI based on creatinine, age, sex, and weight. These equations introduce variability, especially at extremes of age, muscle mass, or renal function. For carboplatin dosing, estimated GFR via Cockcroft–Gault remains the established standard in most oncology centres.

Is a target AUC of 5 always safer than a target AUC of 7?

Lower AUC values do generally reduce toxicity risk, but therapeutic efficacy may be compromised if the dose is too low for the patient's cancer type or disease stage. Oncologists choose the target AUC based on published clinical trial data, the specific regimen, and the patient's diagnosis. A lung cancer protocol might call for AUC 6, while an ovarian cancer protocol might use AUC 7. The 'correct' AUC is the one that balances cure potential against acceptable toxicity for that particular scenario.

How often should kidney function be reassessed during carboplatin treatment?

Kidney function can decline during or after chemotherapy, especially with cumulative carboplatin exposure. Many centres recheck serum creatinine before each carboplatin infusion, particularly after the first or second dose. If creatinine rises by more than 20–30% from baseline or if the patient develops other signs of renal toxicity (e.g., proteinuria), more frequent monitoring or dose reduction may be warranted. Close collaboration between oncology and nephrology is prudent for patients with pre-existing renal disease.

health
ACFT Calculator

More health calculators (see all)

EER (Estimated Energy Requirement) Calculator Heart Failure Life Expectancy Calculator Waist-Hip Ratio Calculator Lung Cancer Risk Calculator for Smokers Waist-to-Height Ratio Calculator Duke Treadmill Score Calculator Anion Gap Calculator BMR Calculator